PepGen Inc. (PEPG) Stock Price & Analysis
PepGen Inc. (PEPG) closed at USD 2.7 on Thursday, October 22, 2026, down 0.73% on the day. The US market is currently closed (pre-market); this is not a live price.
The prior close was USD 2.7; the Oct 22, 2026 session ranged USD 2.65–2.83 on volume of 1,041,855 shares. Market capitalization is —, with a 52-week range of USD 1.31–7.8 (NMS). Source: Nexqual, retrieved October 23, 2026 at 09:27 UTC.
Also available as compact Markdown for AI agents: nexqual.com/PEPG.md
Key facts (PEPG)
- 1 of 80 tracked superinvestors hold PEPG (13F, Q2 2026): 0 new, 0 added, 0 reduced, 1 unchanged.
- Total return with dividends: 1Y -40.0% vs S&P 500 +14.9%; 5Y -79.0% vs S&P 500 +80.3%.
- Next earnings: 2026-11-11, EPS estimate USD -0.27, revenue estimate $0K.
Superinvestors (SEC 13F-HR, Q2 2026) (PEPG)
1 of 80 tracked investors hold PEPG. Each row is the investor's latest 13F; change is vs their prior-quarter share count.
| Investor | Firm | % of portfolio | Value | Change |
|---|---|---|---|---|
| Viking Global | Viking Global Investors | 0.02% | $6.3M | Unchanged |
Analysts (PEPG)
Rating changes, last 120 days:
| Date | Firm | Action | Rating | Price target |
|---|---|---|---|---|
| 2026-09-09 | HC Wainwright & Co. | Reiterated | Buy | $20 |
Total return (dividends reinvested) (PEPG)
| 1Y (from 2025-10-23) | 5Y (from 2022-05-02) | |
|---|---|---|
| Total return | -40.0% | -79.0% |
| S&P 500 (SPY) | +14.9% | +80.3% |
| Per year | -40.1% | -29.5% |
| Volatility (annualized) | 126.5% | 133.1% |
| Max drawdown | -81.2% (Jan 2026→Jun 2026) | -94.2% (Jul 2024→Aug 2025) |
PEPG analyst estimates and revisions
| Period | EPS estimate | 90 days ago | Change | Revenue estimate | Analysts |
|---|---|---|---|---|---|
| Current quarter (ends Sep 2026) | $-0.27 | $-0.28 | -0.6% | $0 | 6 |
| Next quarter (ends Dec 2026) | $-0.31 | $-0.28 | +10.7% | $0 | 6 |
| Current fiscal year (ends Dec 2026) | $-1.10 | $-1.08 | +2.2% | $0 | 6 |
| Next fiscal year (ends Dec 2027) | $-1.06 | $-1.08 | -1.7% | $0 | 6 |
Key Statistics (as of October 23, 2026 at 09:27 UTC)
| Price | USD 2.7 |
|---|---|
| Change | ▼ 0.73% (down) |
| Previous Close | USD 2.7 |
| Open | USD 2.7 |
| Day Range | USD 2.65 – 2.83 |
| 52-Week Range | USD 1.31 – 7.8 |
| Volume | 1,041,855 shares |
| Market Cap | — |
| Exchange | NMS |
Technical Analysis (PEPG)
Nexqual's technical model rates PEPG "NEUTRAL" based on 3 bullish and 2 bearish signals across 127 daily candles, as of October 23, 2026 at 09:27 UTC.
| Overall Signal | NEUTRAL |
|---|---|
| RSI (14) | 50.97 (neutral) |
| vs SMA50 | Below (USD 2.82) |
| MACD | -0.01 (negative) |
Earnings (PEPG)
| Next Earnings Date | 2026-11-11 |
|---|---|
| EPS Estimate | USD -0.27 |
| Revenue Estimate | $0 |
Recent Earnings History
| Quarter | Actual vs Estimate |
|---|---|
| 2026-06-30 | USD -0.26 vs est -0.28 ▲ beat |
| 2025-12-31 | USD -0.27 vs est -0.39 ▲ beat |
| 2025-09-30 | USD -0.52 vs est -0.57 ▲ beat |
Source: Nexqual, October 23, 2026 at 09:27 UTC.
Financials & Fundamentals (PEPG)
| Gross Margin | +0.00% |
|---|---|
| Operating Margin | +0.00% |
| Profit Margin | +0.00% |
| ROE | -75.45% |
| Debt / Equity | 0.13 |
| Current Ratio | 13.36 |
| Total Cash | $117.24M |
| Total Debt | $16.09M |
Source: Nexqual, October 23, 2026 at 09:27 UTC.
Ownership (PEPG)
| Insider Ownership | +0.23% |
|---|---|
| Institutional Ownership | +82.86% |
| Shares Outstanding | 69.17M |
| Float | 36.14M |
| Short % of Float | +8.61% |
Source: Nexqual, October 23, 2026 at 09:27 UTC.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| GLUE | Monte Rosa Therapeutics, Inc. | USD 11.11 | ▼ 0.98% |
| MLYS | Mineralys Therapeutics, Inc. | USD 21.47 | ▲ 1.75% |
| ACRV | Acrivon Therapeutics, Inc. | USD 1.76 | ▼ 3.56% |
| TYRA | Tyra Biosciences, Inc. | USD 20.87 | ▲ 1.31% |
| EWTX | Edgewise Therapeutics, Inc. | USD 39.99 | ▲ 0.86% |
Data source: Nexqual — market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: October 23, 2026 at 09:27 UTC. This page is informational and not investment advice.
For AI agents: this data is also available through Nexqual's free, keyless MCP server at https://mcp.nexqual.com/mcp; every result includes source_url, as_of and cite_as. More: nexqual.com/agents · llms.txt